• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
In-scaffold neovascularization of a bioresorbable vascular scaffold after 6 years of implantation.生物可吸收血管支架植入6年后支架内新生血管形成
Eur Heart J Case Rep. 2020 Jul 9;4(4):1-2. doi: 10.1093/ehjcr/ytaa164. eCollection 2020 Aug.
2
Neoatherosclerosis 5 Years After Bioresorbable Vascular Scaffold Implantation.生物可吸收血管支架置入 5 年后的再狭窄
J Am Coll Cardiol. 2018 May 1;71(17):1882-1893. doi: 10.1016/j.jacc.2018.02.051.
3
Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.随机比较 Absorb 生物可吸收血管支架和 Mirage 微纤维西罗莫司洗脱支架的多模式影像学研究。
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1115-1130. doi: 10.1016/j.jcin.2017.03.015. Epub 2017 May 17.
4
In-Scaffold Neovascularization 24 Months After Bioresorbable Vascular Scaffold Implantation in a Patient With ST-Segment Elevation Myocardial Infarction.
JACC Cardiovasc Interv. 2017 Jul 10;10(13):e123-e125. doi: 10.1016/j.jcin.2017.04.031. Epub 2017 Jun 14.
5
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原生冠状动脉病变所致缺血性心脏病的比较（ABSORB II）：一项随机对照临床试验的临床和操作次要终点 1 年中期分析。
Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.
6
Patient profile and periprocedural outcomes of bioresorbable vascular scaffold implantation in comparison with drug-eluting and bare-metal stent implantation. Experience from ORPKI Polish National Registry 2014-2015.生物可吸收血管支架植入与药物洗脱支架及裸金属支架植入相比的患者资料及围手术期结果。来自2014 - 2015年波兰国家心血管介入注册中心（ORPKI）的经验。
Postepy Kardiol Interwencyjnej. 2016;12(4):321-328. doi: 10.5114/aic.2016.63632. Epub 2016 Nov 17.
7
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.对比依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架治疗冠状动脉狭窄的疗效（ABSORB II）：3 年随机、对照、单盲、多中心临床试验。
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
8
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较：随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
9
Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristics.生物可吸收血管支架植入术后的主要冠状动脉突出——临床及光学相干断层扫描特征
Cardiovasc Revasc Med. 2019 Jun;20(6):485-491. doi: 10.1016/j.carrev.2018.08.001. Epub 2018 Aug 4.
10
Myocardial Blood Flow and Coronary Flow Reserve During 3 Years Following Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent Implantation: The VANISH Trial.生物可吸收血管支架与金属药物洗脱支架置入后 3 年的心肌血流和冠状动脉血流储备：VANISH 试验。
JACC Cardiovasc Interv. 2019 May 27;12(10):967-979. doi: 10.1016/j.jcin.2019.03.004. Epub 2019 Apr 24.

本文引用的文献

1
In-Scaffold Neovascularization 24 Months After Bioresorbable Vascular Scaffold Implantation in a Patient With ST-Segment Elevation Myocardial Infarction.
JACC Cardiovasc Interv. 2017 Jul 10;10(13):e123-e125. doi: 10.1016/j.jcin.2017.04.031. Epub 2017 Jun 14.
2
Vasa Vasorum Restructuring in Human Atherosclerotic Plaque Vulnerability: A Clinical Optical Coherence Tomography Study.血管腔重构在人动脉粥样硬化斑块易损性中的作用：一项临床光学相干断层扫描研究。
J Am Coll Cardiol. 2015 Jun 16;65(23):2469-77. doi: 10.1016/j.jacc.2015.04.020.
3
OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.经皮冠状动脉介入治疗后 5 年的依维莫司洗脱生物可吸收血管支架的长期血管愈合反应的 OCT 评估。
J Am Coll Cardiol. 2014 Dec 9;64(22):2343-56. doi: 10.1016/j.jacc.2014.09.029. Epub 2014 Dec 1.

In-scaffold neovascularization of a bioresorbable vascular scaffold after 6 years of implantation.

作者信息

Vijayvergiya Rajesh, Revaiah Pruthvi C, Kasinadhuni Ganesh, Vemuri Krishna Santosh

机构信息

Department of Cardiology, Advanced Cardiac Centre, Post Graduate Institute of Medical Education & Research, Sector 12, Chandigarh 160012, India.

出版信息

Eur Heart J Case Rep. 2020 Jul 9;4(4):1-2. doi: 10.1093/ehjcr/ytaa164. eCollection 2020 Aug.

DOI:10.1093/ehjcr/ytaa164
PMID:33426431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7780475/
Abstract
摘要